EVI and partners awarded contract by EDCTP

Integrating capacity-building and networking in the design and conduct of Phase I and II clinical trials of viral vectored candidate malaria vaccines in East and West African children and infants Malaria Vectored Vaccines Consortium (MVVC).

The overall objective of the project is to develop a safe, non-reactogenic, effective and affordable malaria vaccine for use by the malaria endemic populations of the world. The project also aims to integrate capacity building and networking in the design and conduct of Phase I and II clinical trials of viral vectored candidate malaria vaccines in African children and infants.